Optimizing biologically targeted clinical trials for neurofibromatosis

Authors

David H. Gutmann, Washington University in St. Louis
Jaishri O. Blakeley, Johns Hopkins University
Bruce R. Korf, University of Alabama at Birmingham
Roger J. Packer, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

4-2013

Journal

Expert Opinion on Investigational Drugs

Volume

Volume 22, Issue 4

Inclusive Pages

443-462

APA Citation

Gutmann, D. H., Blakeley, J. O., Korf, B. R., & Packer, R. J. (2013). Optimizing biologically targeted clinical trials for neurofibromatosis. Expert Opinion on Investigational Drugs, 22(4), 443-462.

Peer Reviewed

1